Accessibility: Skip TopNav
Figure 1
Figure 1. Patients achieving clinically meaningful reductions in HbA1c, 2-hour glucose in the OGTT or use of antidiabetic medications.
Format
JPEG
Quelle:
Corcept Therapeutics Incorporated
Downloads
Originalgröße
Groß
Mittel
Klein